Applied DNA Sciences Appoints Four New Members of the Board of Directors
August 17 2011 - 8:30AM
Marketwired
Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based
security, anti-counterfeiting technology and product authentication
solutions, announced the election of four new members to its Board
of Directors: John Bitzer III, President & Chief Executive
Officer of ABARTA, Inc.; Gerald Catenacci, Neustrada Capital LLC;
Karol Gray, Vice President for Finance & Administration and the
Chief Financial Officer at the University at Stony Brook and
Charles Ryan, Sr. Vice President and Chief Intellectual Property
Counsel at Forest Laboratories.
"The expansion of APDN's Board of Directors ensures the company
will continue to benefit from a diversity of experience and
opinions. After an extensive search, we determined these were the
best candidates because of their proven leadership skills, broad
management experience in established companies, and their
reputation as independent thinkers," stated Dr. James Hayward,
President and CEO, APDN.
Dr. Charles Ryan earned a doctorate in oral biology and
pathology from SUNY Stony Brook and a law degree from Western New
England College School of Law. Dr. Ryan is the Sr. Vice President,
and Chief Intellectual Property Counsel at Forest Laboratories,
where he has been employed since 2003. Forest, with a market
capitalization of nearly $10 billion, develops branded drugs,
including Lexapro and Celexa, used to treat depression, Benicar,
for hypertension and Aerobid, a metered dose inhaler for
asthma.
Karol Gray is Chief Financial Officer of the Stony Brook
Foundation and the Vice President for Finance & Administration
at Stony Brook University, an organization she has served for over
33 years. As Chief Financial Officer for the Stony Brook
Foundation, Ms. Gray provides financial direction and support for
the Budget, Investment, and Realty Committees. Ms. Gray is
responsible for the University financial operation as well as the
Foundation's net assets of $200 million. She is active on several
committees, including the Brookhaven National Laboratory Audit
Committee, the Presidential Budget Working Group, and the
Investment Subcommittee of the Research Foundation of the State
University of New York, and is a member of the Executive Committee
of the State University of New York Business and Officers
Association. Ms. Gray has a Bachelor in Business Administration
from Hofstra University and currently serves as Treasurer of
Faculty Student Association.
John Bitzer, III, is President & Chief Executive Officer of
ABARTA, Inc., a private, fourth-generation family holding-company
with operations in the soft drink beverages, newspaper publishing,
oil and gas exploration and development, and frozen food
industries. In 1985, Mr. Bitzer began his career in sales for the
Cleveland Coca-Cola Bottling Company. He has been Publisher of
Atlantic City Magazine in Atlantic City, N.J. In 1994 he founded
the ABARTA Media Group and held the position of Group Publisher. In
1997 he was named President & Chief Operating Officer of
ABARTA, Inc. and has been President & Chief Executive Officer
since 1999. He is a director of the Institute for Entrepreneurial
Excellence at the University of Pittsburgh. Mr. Bitzer has a degree
from the University of Southern California and an MBA from the
University of Michigan. Mr. Bitzer stated: "I look forward to
working with Dr. Hayward and the rest of the Applied DNA Sciences
board in making our vision for the company a reality."
Gerald Catenacci is the Founder and President of Neustrada
Capital, LLC, a private investment fund. Mr. Catenacci obtained a
Bachelor of Science in Civil Engineering from McMaster University
in 1985, and has spent his career in equity management. Mr.
Catenacci was the Founding Partner and Managing Director Principled
Capital Management, a successful hedge fund that operated in New
York City from 1998 to 2010.
These additions increase the number of APDN directors to seven.
Dr. James Hayward, chairman, president and chief executive officer
of Applied DNA Sciences, Dr. Yacov Shamash, Vice President of
Economic Development and Dean of the College of Engineering at the
State University of New York at Stony Brook, and Dr. Sanford Simon,
Professor of Biochemistry, Cell Biology and Pathology at the State
University of New York at Stony Brook continue to serve on the
Board.
About APDN APDN sells patented DNA
security solutions to protect products, brands and intellectual
property from counterfeiting and diversion. SigNature DNA is a
botanical mark used to authenticate products in a unique manner
that essentially cannot be copied. Our mark provides a forensic
chain of evidence that can be used to prosecute perpetrators. To
learn more, go to www.adnas.com where APDN routinely posts all
press releases.
The statements made by APDN may be forward-looking in nature.
Forward-looking statements describe APDN's future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to
time in APDN's SEC reports and filings, including our Annual Report
on Form 10-K, filed on December 15, 2010 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events.
INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848
MEDIA CONTACT: Mitchell Miller 917-573-3373 fax: 631-444-8848 FCMN
Contact: Email Contact Web site: http://www.adnas.com Twitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024